| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.25 | 2e-07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.2 | 9e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.09 | 0.08 |